Last update Jan. 26, 2019
Hydrolipoclasia is a procedure made up of two others: mesotherapy and subsequent ultracavitation. It is used with the purported effects of reducing fat located in the waist, thighs or hips.
There is no evidence of the usefulness of this practice and the only existing publication in a scientific journal (Herreros 2009) is about its possible adverse effects, in particular, infection by atypical mycobacteria, as occurs in mesotherapy procedures.
Since the last update we have not found published data on its compatibility with breastfeeding.
The risk for breastfeeding or the infant depends on which product is injected under the skin, since its systemic absorption has been proven and, therefore, it could reach breastmilk.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.